CD8A and breast carcinoma: Folr2 expression is associated with protumor macrophages that exhibit an anti-inflammatory and immunosuppressive microenvironment in several cancers (44); however, in some indications (e.g., breast cancer), it has been associated with CD8+ T cell infiltration and better patient survival (44).